BioMarin Pharmaceutical Inc (MIL:1BMRN)
€ 57.18 (0%) Market Cap: 10.90 Bil Enterprise Value: 13.76 Bil PE Ratio: 177.08 PB Ratio: 2.01 GF Score: 59/100

BioMarin Pharmaceutical Inc. at Citi Biopharma Back to School Summit Transcript

Sep 10, 2026 / 05:00 PM GMT
Release Date Price: €57.18


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BMRN.OQ - BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. at Citi Biopharma Back to School Summit
Sep 10, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, everyone. Well, welcome to day two of Citi's Back-to-School Biopharma Conference. I'm Eric Joseph, Senior Biotech Analyst with the firm. And this session is with BioMarin, and I'm happy to be joined by Chief R&D Officer, Greg Freberg, and Chief Commercial Officer, Kristen Hubbard.

Thank you both for joining us here.

Maybe just before we kind of dig into.

Questions, it would be good to kind of have some high-level remarks from you both and just what some of the key priorities are at the company looking over the next six, 12 months?

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot